Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy-Reference-Cited by-同舟云学术

Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy

Published:2022-11-03 Issue:5 Volume:72 Page:1089-1102
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Rutihinda Cleopatra,Haroun Ryma,Saidi Nour Elhouda,Ordoñez Juan Pablo,Naasri Sahar,Lévesque Dominique,Boisvert François-Michel,Fortier Pierre-Hugues,Belzile Mathieu,Fradet Laurent,Hubert-Tremblay Vincent,Turgeon Guy Anne,Wang Chang Shu,Delage Patrick,Rousseau Étienne,Paquette Benoît,Oweida Ayman J.

Funder

Canada Research Chairs

Cancer Research Society

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-022-03313-2.pdf

Reference49 articles.

1. McDonald MW et al (2011) ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys 80:1292–1298. https://doi.org/10.1016/j.ijrobp.2011.02.014

2. Bonner JA et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578. https://doi.org/10.1056/NEJMoa053422